Answers are grounded in this paper and cite their sources.
"Multidrug resistance in lymphoma: Is it time for clinical trials?." Leukemia & Lymphoma, 48(4), pp. 643–644
No takes yet. Share an insight, caveat, or question.
Deborah Rund (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: